DT Investment Partners LLC boosted its stake in HCP, Inc. (NYSE:HCP) by 20.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 46,253 shares of the real estate investment trust’s stock after buying an additional 7,871 shares during the period. DT Investment Partners LLC’s holdings in HCP were worth $1,478,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in HCP. Cleararc Capital Inc. boosted its stake in HCP by 0.7% in the first quarter. Cleararc Capital Inc. now owns 11,441 shares of the real estate investment trust’s stock valued at $358,000 after buying an additional 85 shares in the last quarter. Peoples Financial Services CORP. boosted its stake in HCP by 4.0% in the second quarter. Peoples Financial Services CORP. now owns 3,250 shares of the real estate investment trust’s stock valued at $104,000 after buying an additional 125 shares in the last quarter. Transamerica Financial Advisors Inc. boosted its stake in HCP by 0.9% in the first quarter. Transamerica Financial Advisors Inc. now owns 17,030 shares of the real estate investment trust’s stock valued at $533,000 after buying an additional 145 shares in the last quarter. Atria Investments LLC boosted its stake in HCP by 1.2% in the second quarter. Atria Investments LLC now owns 12,447 shares of the real estate investment trust’s stock valued at $398,000 after buying an additional 147 shares in the last quarter. Finally, Curbstone Financial Management Corp boosted its stake in HCP by 0.5% in the first quarter. Curbstone Financial Management Corp now owns 31,185 shares of the real estate investment trust’s stock valued at $975,000 after buying an additional 150 shares in the last quarter. 88.87% of the stock is currently owned by institutional investors.
Shares of HCP, Inc. (NYSE:HCP) opened at 28.85 on Friday. HCP, Inc. has a 52 week low of $27.61 and a 52 week high of $40.43. The company has a market cap of $13.53 billion, a price-to-earnings ratio of 19.67 and a beta of 0.37. The company has a 50 day moving average of $30.83 and a 200-day moving average of $31.23.
HCP (NYSE:HCP) last issued its quarterly earnings data on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, topping the consensus estimate of $0.47 by $0.01. The firm had revenue of $458.90 million during the quarter, compared to the consensus estimate of $456.29 million. HCP had a return on equity of 9.96% and a net margin of 32.16%. The company’s quarterly revenue was down 14.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.71 earnings per share. On average, equities research analysts expect that HCP, Inc. will post $1.36 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 22nd. Stockholders of record on Monday, August 7th will be paid a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 5.13%. The ex-dividend date of this dividend is Thursday, August 3rd. HCP’s dividend payout ratio (DPR) is presently 102.07%.
ILLEGAL ACTIVITY WARNING: This article was originally published by BNB Daily and is the property of of BNB Daily. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.baseball-news-blog.com/2017/08/19/hcp-inc-nysehcp-shares-bought-by-dt-investment-partners-llc-updated-updated.html.
HCP has been the topic of several research analyst reports. BidaskClub cut shares of HCP from a “buy” rating to a “hold” rating in a research report on Thursday, June 29th. Zacks Investment Research cut shares of HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. Stifel Nicolaus reissued a “hold” rating and issued a $31.00 target price on shares of HCP in a research report on Friday, July 14th. Goldman Sachs Group, Inc. (The) cut shares of HCP from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $35.00 to $32.00 in a research report on Monday, July 24th. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $31.00 target price on shares of HCP in a research report on Wednesday, July 5th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $33.42.
In other news, insider Thomas Klaritch sold 2,651 shares of the stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the completion of the sale, the insider now directly owns 176,830 shares of the company’s stock, valued at $5,575,449.90. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.22% of the company’s stock.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.